Serina Therapeutics
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Serina Therapeutics's balance sheet done over the years? Its assets were worth $11,965,000 last year, which is more than in the previous period. 55% of Serina Therapeutics’s total assets is currently financed by debt. Its liabilities reached the amount of $6,607,000, which means an decrease by -83% compared compared to last year.

Debt to Assets

Serina Therapeutics Inc (NYSE:SER): Debt to assets
2017 9631000 1.31M 13.62%
2019 7442000 4.82M 64.83%
2020 3925000 9.32M 237.48%
2021 1844407 36.95M 2003.46%
2022 858042 38.63M 4502.83%
2023 11965000 6.60M 55.22%

SER Balance Sheet (2017 – 2023)

2023 2022 2021 2020 2019 2017
Assets
Current assets:
Cash and cash equivalents
345K532.22K314.84K527K2.35M7.37M
Short term investments
00996.44K000
Net receivables
57K4K1.10K326K363K107K
Inventory
0-1.79M-1.60M000
Other current assets
352K1.80M1.62M1.43M1.33M111K
Total current assets
754K548.57K1.33M2.28M4.05M7.59M
Non-current assets:
Property, Plant and Equipment
0309.46K514.15K01.12M129K
Goodwill
000000
Intangible assets
607K00000
Long term investments
10.60M50K50K50K00
Other non-current assets
0-50K-50K1.59M2.26M1.90M
Total non-current assets
11.21M309.46K514.15K1.64M3.38M2.03M
Total assets
11.96M858.04K1.84M3.92M7.44M9.63M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
1153.5K0275K283K180K
Short term debt
3.67M128.40K211.79K2.39M428K0
Total current liabilities
5.91M437.68K371.46K5.35M3.29M1.31M
Non-current liabilities:
Long term debt
693K1.68M186.37K3.9M1.52M0
Deferred tax
000000
Other non-current liabilities
036.51M36.39M-100
Total non-current liabilities
693K38.19M36.58M3.96M1.52M0
Total liabilities
6.60M38.63M36.95M9.32M4.82M1.31M